Role of PTPN2/22 polymorphisms in pathophysiology of Crohn's disease

World J Gastroenterol. 2018 Feb 14;24(6):657-670. doi: 10.3748/wjg.v24.i6.657.

Abstract

Aim: To establish the relationship of protein tyrosine phosphatase non-receptor type 2 and 22 (PTPN2/22) polymorphisms and mycobacterial infections in Crohn's disease (CD).

Methods: All 133 subjects' blood samples were genotyped for nine single nucleotide polymorphisms (SNPs) in PTPN2/22 using TaqMan™ genotyping, while the effect of the SNPs on PTPN2/22 and IFN-γ gene expression was determined using RT-PCR. Detection of Mycobacterium avium subspecies paratuberculosis (MAP) IS900 gene was done by nPCR after DNA extraction from the isolated leukocytes of each subjects' blood samples. T-cells isolated from the patient samples were tested for response to phytohematoagglutonin (PHA) mitogen or mycobacterial antigens by BrdU proliferation assays for T-cell activity.

Results: Out of the nine SNPs examined, subjects with either heterozygous (TC)/minor (CC) alleles in PTPN2:rs478582 occurred in 83% of CD subjects compared to 61% healthy controls (P-values < 0.05; OR = 3.03). Subjects with either heterozygous (GA)/minor (AA) alleles in PTPN22:rs2476601 occurred in 16% of CD compared to 6% healthy controls (OR = 2.7). Gene expression in PTPN2/22 in CD subjects was significantly decreased by 2 folds compared to healthy controls (P-values < 0.05). IFN-γ expression levels were found to be significantly increased by approxiately 2 folds in subjects when either heterozygous or minor alleles in PTPN2:rs478582 and/or PTPN22:rs2476601 were found (P-values < 0.05). MAP DNA was detected in 61% of CD compared to only 8% of healthy controls (P-values < 0.05, OR = 17.52), where subjects with either heterozygous or minor alleles in PTPN2:rs478582 and/or PTPN22:rs2476601 had more MAPbacteremia presence than subjects without SNPs did. The average T-cell proliferation in CD treated with PHA or mycobacteria antigens was, respectively, 1.3 folds and 1.5 folds higher than healthy controls without any significant SNP.

Conclusion: The data suggests that SNPs in PTPN2/22 affect the negative regulation of the immune response in CD patients, thus leading to an increase in inflammation/apoptosis and susceptibility of mycobacteria.

Keywords: Crohn’s disease; Mycobacteria; PTPN2; PTPN2/22; PTPN22; Single nucleotide polymorphisms.

MeSH terms

  • Adult
  • Aged
  • Alleles
  • Antigens, Bacterial / immunology
  • Apoptosis / genetics
  • Apoptosis / immunology
  • Cell Proliferation / drug effects
  • Cell Proliferation / genetics
  • Cells, Cultured
  • Crohn Disease / blood
  • Crohn Disease / genetics*
  • Crohn Disease / immunology
  • Crohn Disease / microbiology
  • DNA, Bacterial / isolation & purification*
  • Female
  • Genetic Predisposition to Disease
  • Heterozygote
  • Humans
  • Male
  • Middle Aged
  • Mitogens / pharmacology
  • Mycobacterium avium subsp. paratuberculosis / genetics
  • Mycobacterium avium subsp. paratuberculosis / immunology
  • Paratuberculosis / blood
  • Paratuberculosis / genetics*
  • Paratuberculosis / immunology
  • Paratuberculosis / microbiology
  • Phytohemagglutinins / pharmacology
  • Polymorphism, Single Nucleotide
  • Protein Tyrosine Phosphatase, Non-Receptor Type 2 / genetics*
  • Protein Tyrosine Phosphatase, Non-Receptor Type 22 / genetics*
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / immunology
  • Young Adult

Substances

  • Antigens, Bacterial
  • DNA, Bacterial
  • Mitogens
  • Phytohemagglutinins
  • PTPN2 protein, human
  • PTPN22 protein, human
  • Protein Tyrosine Phosphatase, Non-Receptor Type 2
  • Protein Tyrosine Phosphatase, Non-Receptor Type 22